Literature DB >> 11566000

Hitting a new target with echinocandins. Why chase something else?

J R Graybill1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11566000

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


× No keyword cloud information.
  5 in total

1.  Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates.

Authors:  Sevtap Arikan; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

2.  Efficacy of micafungin alone or in combination against systemic murine aspergillosis.

Authors:  Javier Capilla Luque; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

3.  International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

Authors:  L Ostrosky-Zeichner; D Kontoyiannis; J Raffalli; K M Mullane; J Vazquez; E J Anaissie; J Lipton; P Jacobs; J H Jansen van Rensburg; J H Rex; W Lau; D Facklam; D N Buell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-10       Impact factor: 3.267

Review 4.  Regulation of expression, activity and localization of fungal chitin synthases.

Authors:  Luise E Rogg; Jarrod R Fortwendel; Praveen R Juvvadi; William J Steinbach
Journal:  Med Mycol       Date:  2011-04-28       Impact factor: 4.076

Review 5.  Micafungin.

Authors:  Blair Jarvis; David P Figgitt; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.